| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Dawson Bruce Neil | Chief Sales and CS Officer | C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON | Lisa Lenstrohm, Attorney-in-Fact | 17 Sep 2025 | 0001973708 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Common Shares | Options Exercise | $154,166 | +8,114 | +154% | $19.00 | 13,371 | 16 Sep 2025 | Direct | |
| transaction | IBEX | Common Shares | Sale | $309,468 | -8,114 | -61% | $38.14 | 5,257 | 16 Sep 2025 | Direct | |
| transaction | IBEX | Common Shares | Sale | $29,292 | -765 | -15% | $38.29 | 4,492 | 16 Sep 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $38.2901 to $38.35; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |